Weekly Update
13 November 2026

Medicinal Cannabis Matters: Friday Roundup - 13 November 2026

Welcome to this week’s round-up in medicinal cannabis where we explore new research into different treatment responses among people living with chronic pain, patient-reported improvements in mental wellbeing and what employees and employers need to understand about prescribed medicinal cannabis in the workplace.

5 min read
Medicinal Cannabis Matters: Friday Roundup - 13 November 2026

Five Patterns of Response to Medicinal Cannabis for Chronic Pain

A new analysis of the British Medical Cannabis Registry has explored how people living with chronic pain respond to medicinal cannabis over time.

The study followed 3,744 patients for up to 24 months, measuring changes in pain severity, daily functioning, sleep and quality of life. On average, patients experienced improvements across all these areas, although researchers identified five distinct patterns of treatment response, ranging from substantial to more modest improvements.

One of the key findings was that a patient's sleep quality, anxiety levels and underlying pain condition appeared to be closely associated with their treatment response. The findings offer valuable insight into real-world patient experiences, but the researchers acknowledge important limitations. As the registry study did not include a control group, it cannot prove that medicinal cannabis alone caused the reported improvements.

Nevertheless, the research adds to our understanding of chronic pain and highlights why personalised assessment and ongoing monitoring are important when prescribing medicinal cannabis.

Mental Health Improvements Following Medicinal Cannabis Treatment

A new patient survey has found that more than eight in ten men who reported that their health conditions had affected their mental wellbeing experienced an improvement after starting prescribed medicinal cannabis.

As reported by Leafie, the survey gathered responses from 2,683 active patients, including 1,807 men. Almost half of the male respondents said their condition had affected their mental wellbeing before treatment, with 82% of this group reporting an improvement afterwards. Across all male respondents, 61% said treatment had helped their anxiety or depression.

The findings also highlight how long-term health conditions can affect more than physical symptoms. Many participants reported difficulties with work and personal relationships, while a significant proportion had lived with their symptoms for more than ten years and tried several other treatments before accessing medicinal cannabis.

The survey also highlights the stigma some patients continue to experience, with nearly a third of male respondents saying they had tried to hide their medicinal cannabis prescription from others.

Medicinal Cannabis in the Workplace

As more people in the UK access medicinal cannabis on prescription, questions around workplace drug testing, safety and employee rights are becoming increasingly important.

A new guide from Cannabis Health explores the responsibilities of employers and the considerations for employees who use prescribed medicinal cannabis. Although medicinal cannabis has been legally available on prescription since November 2018, workplace policies have not always kept pace with the changing treatment landscape.

The article discusses the employment tribunal case of Truman v SPL Powerlines, which brought attention to how prescribed medicinal cannabis should be considered within workplace drug-testing policies. The Employment Appeal Tribunal highlighted the need to properly consider an employee's individual circumstances and relevant protections under the Equality Act 2010.

For employers, this highlights the importance of having clear policies, considering legitimate prescriptions and assessing the specific requirements of an employee's role. For patients, it is important to understand their workplace responsibilities and discuss any concerns about treatment or their duties with their prescribing clinician.

This week's stories highlight the importance of understanding medicinal cannabis beyond the prescription itself. Every patient's experience is different, and treatment decisions should reflect their individual needs and circumstances.

If you would like to explore whether medicinal cannabis may be suitable for you, our online eligibility checker takes around two minutes to complete and offers a straightforward first step towards understanding your options.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.

Gary Whipp

Written by

Gary Whipp

Chief Executive Officer

Gary founded Medicann in 2019 with a simple goal: to make safe, affordable access to medical cannabis easier for patients. He led Medicann to become the first clinic in Jersey to issue a medical cannabis prescription, and has since grown the business into a trusted network of clinics across the Channel Islands, the Isle of Man and the UK.

Share